US EditionPublished • loading... • Updated
Amgen (NASDAQ:AMGN) Downgraded to “Hold” Rating by Freedom Capital
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amgen (NASDAQ:AMGN) Downgraded to “Hold” Rating by Freedom Capital
Freedom Capital cut shares of Amgen (NASDAQ:AMGN – Free Report) from a strong-buy rating to a hold rating in a research note published on Thursday morning,Zacks.com reports. Other equities analysts have also recently issued research reports about the stock. HSBC reaffirmed a “buy” rating and issued a $425.00 price target on shares of Amgen in […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
